[Pathogenetic rationale for inclusion of vitamin E in combined correction of iron deficiency anemia].
Kuzdenbaeva
R S
RS
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000378:metabolism; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005296:Ferrous Compounds / Q000627:therapeutic use*; D006801:Humans; D015227:Lipid Peroxidation; D009077:Mucins / Q000627:therapeutic use; D017382:Reactive Oxygen Species / Q000378:metabolism; D014810:Vitamin E / Q000627:therapeutic use*
D000975:Antioxidants; D004338:Drug Combinations; D005296:Ferrous Compounds; D009077:Mucins; D017382:Reactive Oxygen Species; D014810:Vitamin E; C020748:ferrous sulfate; C029015:Ferroplex; C009380:ferrous sulfate, mucin drug combination; D001205:Ascorbic Acid